IPO Databook: JPJ (TCM) Limited(TCM) (HK) - Jul 2026

137 Views19 Jul 2026 10:16

SUMMARY

JPJ (TCM) Limited is a leading Hong Kong-based proprietary Chinese medicine group with a vertically integrated business model centered on trusted heritage brands.
Ranked first in Hong Kong PCM market by end-market sales in 2025 (9.2% share), revenue grew 16.9% CAGR from HK$339.3M (FY2024) to HK$463.8M (FY2026).
FY2026 revenue was HK$463,814, with profit for the year at HK$80,893, but net current liabilities reached HK$506.8 million.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

Try Now

Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

SMARTKARMA PREVIEW PASS

By signing up, you agree to our
Terms of Use and Privacy Policy.

Already have an account? Sign In Now

Discussions

(Paid Plans Only)

Price Chart(Sign Up to Access)

Insight Stream